• No results found

CONCORD INTERNAL MEDICINE TESTOSTERONE DEFICIENCY PROTOCOL

N/A
N/A
Protected

Academic year: 2021

Share "CONCORD INTERNAL MEDICINE TESTOSTERONE DEFICIENCY PROTOCOL"

Copied!
18
0
0

Loading.... (view fulltext now)

Full text

(1)

CONCORD INTERNAL MEDICINE

TESTOSTERONE DEFICIENCY PROTOCOL

Douglas G. Kelling, Jr., MD

Carmella Gismondi-Eagan, MD, FACP

George C. Monroe, III, MD

Revised April 29, 2012

The information contained in this protocol should never be used as a substitute for

clinical judgment.

The clinician and the patient need to develop an individual treatment plan tailored to

the specific needs and circumstances of the patient.

(2)

Testosterone Deficiency Protocol

Table of Contents

P

AGE

(

S

)

I

NITIAL

E

VALUATION

1-5

T

ESTOSTERONE

T

HERAPY

6-12

BPH

S

YMPTOMS

I

NDEX

Q

UESTIONNAIRE

13

E

PWORTH

S

LEEPINESS

S

CALE

14

B

ED

P

ARTNER

/O

BSERVER

S

LEEPINESS

Q

UESTIONNAIRE

15

(3)

Page 1

TESTOSTERONE PROTOCOL

Symptoms of Depression, Decreased Libido, Erectile Dysfunction, Fatigue, Infertility

or Muscle Weakness

Or

Osteoporosis/Osteopenia by DEXA Scan

And

No hospitalization in the last 3 months and no evidence of Class 3 or Class 4 CHF

Draw 8am Total Testosterone

Total Testosterone > 400ng/dl

No further workup Repeat 8am Total Testosterone

Total Testosterone > 400ng/dl Total Testosterone 200-400ng/dl Total Testosterone < 200ng/dl Normal Free Testosterone No further workup

Repeat total testosterone and Measure calculated 8am Free

Testosterone Total Testosterone 200-400ng/dl Low Free Testosterone Total Testosterone <200ng/dl Measure LH and FSH Levels obtain

DEXA scan if not already done No further workup Measure Prolactin Level, TSH and Free T4 See Page 2 Fasting iron, iron binding

capacity and ferritin

Refer to Page 4 Primary Hypogonadism Elevated Values for LH and FSH “Normal Values” for LH and FSH TSAT < 45 TSAT > 45 No further

evaluation Genotype for

hemochromatosis Determine Karyotype (Klinefelter’s Syndrome)

(4)

Page 2

Free T4

Normal Age > 50 Age < 50 Total Testosterone > 150 Total Testosterone < 150 Low Refer to Page 3 Total Testosterone > 250 Total Testosterone < 250 Refer to Page 3 MRI of Pituitary MRI of Pituitary shows tumor MRI of Pituitary shows no tumor Refer to Endocrinologist Refer to Page 3

(5)

Page 3

Prolactin Level

Normal Prolactin Level Elevated TSH Normal TSH Treat for Hypothyroidism Patient on medication which could elevate

Prolactin Level Refer to Page 16 Once TSH normal Repeat Prolactin Level Normal Prolactin Level Elevated Prolactin Level Hypogonadotropic Hypogonadism Elevated Prolactin Level Yes No If possible switch patient to medication that will not

raise Prolactin level Order MRI of pituitary and refer to Endocrinologist Refer to Page 4

Normal Prolactin Level Remeasure Prolactin level in 3 months

Elevated Prolactin Level Refer to Page 1

Remeasure 8am Total Testosterone

(6)

Page 4

Class III or IV CHF

and/or

History of Prostate or Breast Cancer

No Yes No treatment with Testosterone Yes Symptoms of BPH Refer to Page 13 No Symptoms of Sleep Apnea Refer to Pages 14 & 15

for questionnaires Perform DRE and

PVR by Bladder Scan, obtain urinalysis and PSA

then Refer to Urologist

Discuss with urologist if there is contraindications to treatment

with testosterone

Yes

No treatment with

testosterone Refer to Page 5 after questionnaires

(7)

Page 5

Symptoms of Sleep Apnea Refer to Pages 14 & 15

Yes Sleep apnea present Sleep apnea not present Treat sleep apnea 3 months Repeat 8 am Total Testosterone Refer to Page 1

Measure baseline PSA, Hct and Liver Profile

Do DRE Sleep Study No Abnormal PSA Normal PSA Hct > 50 Hct < 50 Abnormal Liver Panel Normal Liver Panel Abnormal DRE Normal DRE Refer to Urologist Contraindications to testosterone No Testosterone Add Testosterone Protocol in touchworks in patient’s chart Refer to Page 12

No Testosterone Evaluate before starting testosterone Contraindications to testosterone Yes No Refer to Urologist Contraindications to testosterone Yes No No Testosterone No Yes No Testosterone Testosterone Treatment Refer to Page 6

(8)

Page 6

Start or change to Androgel, Androderm 5mg patch or Testim 5G

Measure total serum testosterone level in 14 days

Total testosterone level < 400 Total testosterone level > 700

Refer to Page 11 Refer to Page 8 Total testosterone

level 400-700

Continue present dose of Androgel, Androderm, or

Testim Increase Androgel or Testim

to 7.5G

* Androderm not available in 7.5mg at this time. If possible switch patient to

Testosterone Therapy

Decrease Androgel, or Testim to 2.5G. Androderm to 2.5mg

(9)

Page 7

Change Androgel or Testim to 7.5G

Measure total serum testosterone level in 14 days

Total testosterone level 400-700

Total testosterone level > 700

Increase Androgel or Testim to 10 G Total testosterone level < 400

Continue present dose of Androgel/Testim

Decrease Androgel or Testim to 5G

(10)

Page 8

Change Androgel, Androderm 2.5mg, or Testim to 2.5G

Measure total serum testosterone level in 14 days

Total testosterone level < 400 Total testosterone level > 700

Refer to Page 11 Increase Androgel or

Testim to 5G, increase Andrederm to 5mg.

Repeat 8 AM total serum testosterone in 3 months Total testosterone

level 400-700

Refer to Page 6

Stop Androgel, Androderm or Testim

(11)

Page 9

Increase Androgel or Testim to 10G

Measure total serum testosterone level in 14 days

Total testosterone level 400-700

Total testosterone level > 700

Stop Androgel or Testim and begin IM Testosterone per

protocol-Page 10 Total testosterone level < 400

Refer to Page 11 Decrease Androgel or Testim to 7.5G

(12)

Page 10

IM Testosterone Protocol

Testosterone Cypionate 200 mg IM q 2 weeks

Obtain a total testosterone level 7days after the 4

th

IM

dose.*

Testosterone level > 700 ng/dl Or < 400 ng/dl Testosterone level < 700 ng/dl Or > 400 ng/dl

Adjust dose or frequency Refer to Page 11

*If for patient convenience, lab for testosterone could be pushed to after the 6th dose-to coordinate with recheck of H/H, PSA, DRE, 3 month recheck: notify the patient of risk that if dose is too low or high, there will be a delay in change.

(13)

Page 11

Continue Present dose Testosterone

Obtain Hct 3 months after initiation of therapy then

yearly

Hct <54 Hct >54

Continue present dose testosterone

Stop testosterone until Hct decreases to a safe levels; evaluate patient for hypoxemia and sleep apnea; reinitiate

therapy at reduced rate

Obtain PSA, DRE, symptoms of BPH and sleep apnea 3 months after initiation of therapy, then yearly

PSA stable PSA rising DRE within normal limits DRE enlarging prostate No symptoms BPH Symptoms BPH No symptoms Sleep apnea Consider referral to urologist Consider referral to urologist

Post void residual by bladder scan and

consider referral to urologist

Continue present dose of Testosterone Symptoms Sleep apnea Consider sleep study .

(14)

Page12

PSA Due: _______________

3 mo __________/__________ Then yearly

Rectal Exam Due: ________

3 mo __________/__________ Then yearly

HCT Due/Results

3 mo __________/__________ Then yearly

Testosterone Level

Testosterone Protocol

Patient Name:________________________________

Chart No.: __________________________________

Date Initiated: ______________________________

Dose: ______________________________________

If dose changes, please document here:

_________________________ __________________________ _________________________ __________________________ _________________________ __________________________ _________________________ __________________________

Date Dose Site

Initials

Date Dose Site

Initials

Obtain Hct, PSA, DRE, symptoms of BPH and sleep apnea 3 months after

initiation of therapy, then yearly.

(15)
(16)

Page 14

THE EPWORTH SLEEPINESS SCALE

Name: ______________________________________ Today’s Date: _____________________

Age: __________________ Your Sex (M=Male, F=Female) ___________

How likely are you to doze off or fall asleep in the following situations, in contrast to feeling just

tired? This refers to your usual way of life in recent times. Even if you have not done some of these

things recently, try to work out how they would have affected you. Use the following scale to

choose the most appropriate number for each situation.

Would

never

doze

=

0

Slight chance of dozing = 1

Moderate chance of dozing = 2

High chance of dozing = 3

Situation: (Circle most appropriate

number)

Chance

of

dozing

Sitting and reading

0 1 2 3

Watching TV

0 1 2 3

Sitting, inactive in public place such as a theater or a meeting

0 1 2 3

As a passenger in a car for an hour without a break

0 1 2 3

Lying down to rest in the afternoon when circumstances permit

0 1 2 3

Sitting and talking to someone

0 1 2 3

Sitting quietly after lunch without alcohol

0 1 2 3

In a car, while stopped for a few minutes in traffic

0 1 2 3

(17)

Page 15

BED PARTNER/OBSERVER QUESTIONNAIRE

Patient’s Name: _________________________________ Date completed: _________________

How likely are they to doze off or fall asleep in the following situations, in contrast to feeling just tired? This refers to their usual way of life in recent times. Even if they have not done some of these things recently, try to work out how they would have been affected. Use the following scale to choose the most appropriate number for each situation.

Would never doze = 0 Slight chance of dozing = 1 Moderate chance of dozing = 2 High chance of dozing = 3

Situation: (Circle most appropriate number) Chance of dozing

Sitting and reading 0 1 2 3

Watching TV 0 1 2 3 Sitting, inactive in public place such as a theater or a meeting 0 1 2 3 As a passenger in a car for an hour without a break 0 1 2 3 Lying down to rest in the afternoon when circumstances permit 0 1 2 3 Sitting and talking to someone 0 1 2 3 Sitting quietly after lunch without alcohol 0 1 2 3 In a car, while stopped for a few minutes in traffic 0 1 2 3

Total score (add all responses) _______________

Please circle any of the following statements that apply

1. I sleep in the same room as the patient. 2. I sleep in the same bed as the patient. 3. I sleep in a different room.

4. I have noticed no problem with the patient’s sleep.

5. I have noticed a problem for _____ weeks, months, years (circle one). 6. I am bothered by the patient’s snoring.

7. I am bothered by the patient’s not breathing for a short time. 8. I am bothered by the patient’s restless arm or leg movements. 9. I am bothered by the patient’s getting up at night.

10. I notice that the patient may frequently fall asleep inappropriately (watching TV, reading, etc.). 11. I cannot easily awaken the patient in the morning.

12. I have noticed a change in the patient’s personality in the past ____ weeks, months, years (circle one). How has it changed? ________________________________________________________________ Other comments: ___________________________________________________________________

(18)

Page 16

Medications that Elevate Prolactin Levels

Phenothiazines

Butyrophenones

Monoamine oxidase inhibitors

Tricyclic antidepressants

Methyldopa

Metoclopramide

Amoxapine

Verapamil

Cocaine

Fluoxetine

c:\forms\testosterone1 © Douglas G. Kelling, Jr., MD

References

Related documents

As seen in Figure 4, 19% of the schools offered a face-to-face Bachelor’s in Engineering Management degree, and none of these undergraduate programs offer a hybrid

Before the Tsui Chuk Garden incident occurred, the Department had already embarked on the review of existing Fire Services Training Notes, and the updated version of Fire

In the event that the Offeror has declared the Offer unconditional (gestandgedaan) and has not acquired 95% or more of the outstanding share capital of Athlon following the

If this methodology is used, Scotland saw much lower levels of public expenditure as a proportion of GDP than the UK as a whole during most of the 1980s, with public

Board position statements do not have the force of law, but are a means for providing guidance on issues of concern to the board relevant to protection of the public. Board

Fixture Type SS– Columbia Lighting: Approved.. Fixture Type TP – Tivoli:

A coordination channel might also be at play (Sarno and Taylor, 2001), in which market participants might interpret statements by emerging economies suggesting a weakening

Interestingly, UK GDP shows a significant and positive trend growth rate of 1.28% per annum over the sample period, helping to explain the increasing demand for luxury goods like